1. Home
  2. BA vs VRTX Comparison

BA vs VRTX Comparison

Compare BA & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boeing Company (The)

BA

Boeing Company (The)

HOLD

Current Price

$218.66

Market Cap

144.1B

Sector

Industrials

ML Signal

HOLD

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

HOLD

Current Price

$462.75

Market Cap

115.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BA
VRTX
Founded
1916
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
EDP Services
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
144.1B
115.7B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
BA
VRTX
Price
$218.66
$462.75
Analyst Decision
Strong Buy
Buy
Analyst Count
19
24
Target Price
$241.16
$494.64
AVG Volume (30 Days)
8.5M
1.4M
Earning Date
01-27-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
14.22
Revenue
$80,757,000,000.00
$11,723,300,000.00
Revenue This Year
$36.35
$11.01
Revenue Next Year
$10.06
$8.74
P/E Ratio
N/A
$32.55
Revenue Growth
10.18
10.33
52 Week Low
$128.88
$362.50
52 Week High
$242.69
$519.68

Technical Indicators

Market Signals
Indicator
BA
VRTX
Relative Strength Index (RSI) 69.79 63.15
Support Level $198.05 $445.41
Resistance Level $210.66 $459.05
Average True Range (ATR) 3.97 8.88
MACD 2.19 0.61
Stochastic Oscillator 95.85 95.20

Price Performance

Historical Comparison
BA
VRTX

About BA Boeing Company (The)

Boeing is a major aerospace and defense firm operating in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed Martin and Northrop Grumman to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Share on Social Networks: